Confluence Wealth Services Inc. Has $626,000 Position in CVS Health Corporation (NYSE:CVS)

Confluence Wealth Services Inc. lifted its position in shares of CVS Health Corporation (NYSE:CVS - Free Report) by 131.7% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 9,541 shares of the pharmacy operator's stock after buying an additional 5,423 shares during the period. Confluence Wealth Services Inc.'s holdings in CVS Health were worth $626,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. McIlrath & Eck LLC grew its holdings in shares of CVS Health by 32.6% in the 4th quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock valued at $32,000 after acquiring an additional 174 shares in the last quarter. Horizon Bancorp Inc. IN grew its holdings in shares of CVS Health by 7.4% in the 1st quarter. Horizon Bancorp Inc. IN now owns 2,610 shares of the pharmacy operator's stock valued at $177,000 after acquiring an additional 180 shares in the last quarter. Coppell Advisory Solutions LLC grew its holdings in shares of CVS Health by 17.3% in the 4th quarter. Coppell Advisory Solutions LLC now owns 1,282 shares of the pharmacy operator's stock valued at $56,000 after acquiring an additional 189 shares in the last quarter. Strategic Investment Advisors MI grew its holdings in shares of CVS Health by 2.3% in the 1st quarter. Strategic Investment Advisors MI now owns 8,466 shares of the pharmacy operator's stock valued at $574,000 after acquiring an additional 194 shares in the last quarter. Finally, EagleClaw Capital Managment LLC grew its holdings in shares of CVS Health by 3.4% in the 4th quarter. EagleClaw Capital Managment LLC now owns 6,135 shares of the pharmacy operator's stock valued at $275,000 after acquiring an additional 200 shares in the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at CVS Health

In other news, Director Guy P. Sansone acquired 1,570 shares of the stock in a transaction on Thursday, June 5th. The stock was acquired at an average cost of $63.70 per share, for a total transaction of $100,009.00. Following the completion of the transaction, the director now directly owns 12,007 shares in the company, valued at approximately $764,845.90. This trade represents a 15.04% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. Company insiders own 1.22% of the company's stock.

Analyst Upgrades and Downgrades

CVS has been the subject of several analyst reports. Wells Fargo & Company restated an "overweight" rating and issued a $84.00 price objective (up previously from $76.00) on shares of CVS Health in a report on Tuesday, May 6th. Cowen reiterated a "buy" rating on shares of CVS Health in a report on Monday, May 5th. Wall Street Zen upgraded CVS Health from a "hold" rating to a "buy" rating in a report on Friday, May 9th. Morgan Stanley reiterated an "overweight" rating on shares of CVS Health in a report on Tuesday, April 15th. Finally, UBS Group lifted their price target on CVS Health from $67.00 to $71.00 and gave the stock a "neutral" rating in a report on Friday, May 2nd. Two research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $74.75.

CVS Health Stock Up 0.5%

NYSE CVS opened at $68.50 on Friday. The company has a current ratio of 0.82, a quick ratio of 0.63 and a debt-to-equity ratio of 0.77. CVS Health Corporation has a 1-year low of $43.56 and a 1-year high of $72.51. The company has a 50 day moving average of $64.86 and a 200-day moving average of $60.86. The company has a market cap of $86.66 billion, a price-to-earnings ratio of 16.35, a PEG ratio of 0.98 and a beta of 0.56.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share for the quarter, beating analysts' consensus estimates of $1.62 by $0.63. CVS Health had a net margin of 1.39% and a return on equity of 10.59%. The company had revenue of $94.59 billion during the quarter, compared to the consensus estimate of $93.07 billion. During the same period in the previous year, the business earned $1.31 earnings per share. The firm's quarterly revenue was up 7.0% on a year-over-year basis. On average, equities research analysts expect that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.